Login / Signup
Rapid response of cutaneous lupus erythematosus to treatment with the type I interferon receptor antagonist anifrolumab.
Claudia Günther
Published in:
The British journal of dermatology (2023)
Keyphrases
</>
systemic lupus erythematosus
dendritic cells
disease activity
rheumatoid arthritis
combination therapy
sensitive detection